MARKET

QNRX

QNRX

Quoin Pharmaceuticals Ltd
NASDAQ
4.580
-0.130
-2.76%
After Hours: 4.630 +0.05 +1.09% 19:38 07/02 EDT
OPEN
4.660
PREV CLOSE
4.710
HIGH
4.770
LOW
4.530
VOLUME
39.13K
TURNOVER
--
52 WEEK HIGH
41.80
52 WEEK LOW
3.250
MARKET CAP
9.20M
P/E (TTM)
-0.0079
1D
5D
1M
3M
1Y
5Y
1D
Quoin Pharmaceuticals receives notice of allowance for QRX003 patent
TipRanks · 4d ago
Quoin Pharmaceuticals Issued Notice Of Allowance From U.S. Patent And Trademark Office Titled Combination Treatment For Netherton Syndrome
Benzinga · 4d ago
Weekly Report: what happened at QNRX last week (0622-0626)?
Weekly Report · 5d ago
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
TipRanks · 06/25 12:35
Top Biotech Gainers: PLSM Inks Virtual Maternity Care Deal, ICCM Turns Heads, SLN Hits New High
NASDAQ · 06/25 03:47
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 06/24 12:05
Why Leifras Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Benzinga · 06/24 08:44
Quoin Advances QYLEKI Toward First Netherton Therapy
TipRanks · 06/23 21:45
More
About QNRX
Quoin Pharmaceuticals Ltd, former Cellect Biotechnology Ltd, is an Israel-based specialty pharmaceutical company, focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.

Webull offers Quoin Pharmaceuticals Ltd - ADR stock information, including NASDAQ: QNRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QNRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QNRX stock methods without spending real money on the virtual paper trading platform.